Magnesium sulfate and ritodrine hydrochloride: a randomized comparison

Area of Science:

• Obstetrics and Gynecology
• Pharmacology
• Perinatology

Background:

• Preterm labor is a significant concern in obstetrics.
• Tocolytic agents are used to inhibit uterine contractions.
• Magnesium sulfate and ritodrine hydrochloride are common tocolytic drugs.

Purpose of the Study:

• To compare the efficacy of magnesium sulfate and ritodrine hydrochloride in managing preterm labor.
• To evaluate the safety and ease of administration of both agents.

Main Methods:

• Prospective randomized trial involving patients in preterm labor (20-35 weeks' gestation).
• Administration of magnesium sulfate versus ritodrine hydrochloride.
• Monitoring of tocolysis duration, delay of delivery, dosage, and side effects.

Main Results:

• Magnesium sulfate achieved tocolysis for >72 hours in 88% of patients; ritodrine hydrochloride in 79%.
• Delivery delay of ≥7 days was achieved in 75% (magnesium sulfate) and 72% (ritodrine hydrochloride) of cases.
• Magnesium sulfate demonstrated a favorable side effect profile and ease of administration.

Conclusions:

• Magnesium sulfate is a clinically efficacious and easily administered first-line tocolytic therapy for preterm labor.
• Ritodrine hydrochloride can serve as a pharmacologic backup to magnesium sulfate.
• Tocolytic action of magnesium sulfate is dose-dependent with easily determinable drug concentrations.